Time course of fluid responsiveness in sepsis: the fluid challenge revisiting (FCREV) study

Crit Care. 2019 May 16;23(1):179. doi: 10.1186/s13054-019-2448-z.

Abstract

Background: Fluid challenge (FC) is one of the most common practices in Intensive Care Unit (ICU). The present study aimed to evaluate whether echocardiographic assessment of the response to FC at the end of the infusion or 20 min later could affect the results of the FC.

Methods: This is a prospective, observational, multicenter study including all ICU patients in septic shock requiring a FC of 500 mL crystalloids over 10 min. Fluid responsiveness was defined as a > 15% increase in stroke volume (SV) assessed by velocity-time integral (VTI) measurements at baseline (T0), at the end of FC (T10), then 10 (T20) and 20 min (T30) after the end of FC.

Results: From May 20, 2014, to January 7, 2016, a total of 143 patients were enrolled in 11 French ICUs (mean age 64 ± 14 years, median IGS II 53 [43-63], median SOFA score 10 [8-12]). Among the 76/143 (53%) patient responders to FC at T10, 37 patients were transient responders (TR), i.e., became non-responders (NR) at T30 (49%, 95%CI = [37-60]), and 39 (51%, 95%CI = [38-62]) patients were persistent responders (PR), i.e., remained responders at T30. Among the 67 NR at T10, 4 became responders at T30, (6%, 95%CI = [1.9-15.3]). In the subgroup analysis, no statistical difference in hemodynamic and echocardiographic parameters was found between groups.

Conclusions: This study shows that 51.3% of initial responders have a persistent response to fluid 30 min after the beginning of fluid infusion and only 41.3% have a transient response highlighting that fluid responsiveness is time dependent.

Trial registration: ClinicalTrials.gov , NCT02116413 . Registered on April 16, 2014.

Keywords: Echocardiography; Fluid challenge; Fluid responsiveness; ICU; Shock.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Aged
  • Arterial Pressure / drug effects
  • Arterial Pressure / physiology
  • Cardiac Output / drug effects
  • Cardiac Output / physiology
  • Crystalloid Solutions / therapeutic use
  • Echocardiography / methods
  • Female
  • Fluid Therapy / methods*
  • France
  • Humans
  • Intensive Care Units / organization & administration
  • Intensive Care Units / statistics & numerical data
  • Male
  • Middle Aged
  • Prospective Studies
  • Sepsis / physiopathology
  • Sepsis / therapy*
  • Time Factors*

Substances

  • Crystalloid Solutions

Associated data

  • ClinicalTrials.gov/NCT02116413